trans-1,4-bis(2-chlorobenzaminomethyl)cyclohexane dihydrochloride has been researched along with guanosine 5'-o-(2-thiodiphosphate) in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Liu, Q; Lukas, RJ; Wakui, M; Wang, MY; Whiteaker, P; Wu, J; Zheng, C | 1 |
1 other study(ies) available for trans-1,4-bis(2-chlorobenzaminomethyl)cyclohexane dihydrochloride and guanosine 5'-o-(2-thiodiphosphate)
| Article | Year |
|---|---|
U18666A, a cholesterol-inhibition agent, modulates human neuronal nicotinic acetylcholine receptors heterologously expressed in SH-EP1 cell line.
Topics: Androstenes; Anticholesteremic Agents; Biophysical Phenomena; Cell Line, Transformed; Dose-Response Relationship, Drug; Electric Stimulation; Epithelial Cells; Gene Expression; Guanosine Diphosphate; Humans; Membrane Potentials; Nicotine; Patch-Clamp Techniques; Receptors, Nicotinic; Thionucleotides; trans-1,4-Bis(2-chlorobenzaminomethyl)cyclohexane Dihydrochloride | 2009 |